SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • 1
    Deitch AD. The effect of cytotoxicity on DNA histograms. Cytometry 1987; 8: 339.
  • 2
    Bauer KD. Quality control issues in DNA content flow cytometry. Ann NY Acad Sci 1993; 677: 5977.
  • 3
    Wersto RP, Stetler-Stevenson MA. Debris compensation of DNA histograms and its effect on S-phase analysis. Cytometry 1995; 20: 4352.
  • 4
    Heiden T, Castro J, Graf B-M, Tribukait B. Comparison of routine flow cytometric DNA analysis of fresh tissues in two laboratories: effects of differences in preparation methods and background models of cell cycle calculation. Cytometry 1998; 34: 187197.
  • 5
    Dressler LG, Bartow SA. DNA flow cytometry in solid tumors: practical aspects and clinical applications. Semin Diagn Pathol 1989; 6: 5582.
  • 6
    Bach BA, Knape WA, Edinger MG, Tubbs RR. Improved sensitivity and resolution in the flow cytometric DNA analysis of human solid tumor specimens. Am J Clin Pathol 1991; 96: 615627.
  • 7
    Sharpless TK, Melamed MR. Estimation of cell size from pulse shape in flow cytofluorimetry. J Histochem Cytochem 1976; 24: 257264.
  • 8
    Sharpless T, Traganos F, Darzynkiewicz Z, Melamed MR. Flow cytofluorimetry: discrimination between single cells and cell aggregrates by direct size measurements. Acta Cytol 1975; 19: 577581.
  • 9
    Steinkamp JA. Flow cytometry. Rev Sci Instr 1984; 55: 13751400.
  • 10
    Gong J, Traganos F, Darzynkiewicz Z. Simultaneous analysis of cell cycle kinetics at two different DNA ploidy levels based on DNA content and cyclin B measurements. Cancer Res 1993; 53: 50965099.
  • 11
    Rabinovitch PS. Practical considerations for DNA content and cell cycle analysis. In: BauerKD, DuqueRE, ShankeyTV, editors. Clinical flow cytometry. Principles and application. Baltimore: Williams and Wilkins; 1993. p 117142.
  • 12
    Funai S, Kurooka K, Fujii Y, Inufusa H, Yamada H, Imanishi Y, Sato S, Shinko K, Yasutomi M. Multicycle software for cell cycle analyses. Gan To Kagaku Ryoho 1994; 21: 102107.
  • 13
    Torres FX, Mackowiak PG, Brown RD, Linden MD, Zarbo RJ. Comparison of two methods of mechanical disaggregation of scirrhous breast adenocarcinomas for DNA flow cytometric analysis of whole cells. Am J Clin Pathol 1995; 103: 813.
  • 14
    Bergers E, Montironi R, van Diest PJ, Prete E, Baak JP. Interlaboratory reproducibility of semiautomated cell cycle analysis DNA histograms obtained from fresh material of 1,295 breast cancer cases. Hum Pathol 1996; 27: 553560.
  • 15
    Shapiro HM. Practical flow cytometry. 3rd ed. New York: Wiley-Liss; 1995.
  • 16
    Rudolph NS, Ohlsson-Wilhelm BM, Leary JF, Rowley PT. Single-cell analysis of the relationships between transferrin receptors, proliferation, and cell cycle phase in K562 cells. Cytometry 1985; 6: 151158.
  • 17
    McDivitt RW, Stone KR, Craig RB, Palmer JO, Meyer JS, Bauer WC. A proposed classification of breast cancer based on kinetic information. Cancer 1996; 75: 269276.
  • 18
    Dressler LG, Seamer LC, Owebs MA, Clark GM, McGuire WL. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer 1988; 61: 420427.
  • 19
    Clark GM, Dressler LG, Owens MA, Pounds G, Oldaker T, McGuire WL. Predication of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. N Engl J Med 1989; 320: 627633.
  • 20
    Sigurdsson H, Baldetorp B, Borg A, Dalherg M, Ferno M, Killander D, Olsson H. Indicators of prognosis in node-negative breast cancer. 1990. N Engl J Med 1990; 322: 10451053.
  • 21
    O'Reilly SM, Richards MA. Is DNA flow cytometry a useful investigation in breast cancer? Eur J Cancer 1992; 28: 504507.
  • 22
    Balslev I, Christensen IJ, Brunn Rasmussen B, Larsen JK, Lykkesfedlt AE, Thorpe SM, Rose C, Briand P, Mouridsen HT. Flow cytometric DNA ploidy defines patients with poor prognosis in node-negative breast cancer. Int J Cancer 1994; 56: 1625.
  • 23
    Bryant J, Fisher B, Gunduz N, Costantino JP, Emir B. S-phase fraction combined with other patient characteristics for the prognosis of node-negative, estrogen-receptor-positive breast cancer. Breast Cancer Res Treat 1998; 51: 239253.
  • 24
    Wenger CR, Clark GM. S-phase fraction and breast cancer—a decade of experience. Breast Cancer Res Treat 1998; 51: 255265.
  • 25
    Shankey TV, Rabinovitch PS, Bagwell B, Bauer KD, Duque RE, Hedley DW, Mayall BH, Wheeless L. Guidelines or implementation of clinical DNA cytometry. Cytometry 1993; 14: 472477.
  • 26
    Vindelöv LL, Christensen IJ, Nissen NI. A detergent trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983; 3: 323327.
  • 27
    Wersto RP, Rosenthal ER, Seth PK, Eissa NT, Donahue RE. Recombinant, replication-deficient adenoviral gene transfer vectors induce cell cycle dysregulation and inappropriate expression of cyclin proteins. J Virol 1998; 72: 94919502.
  • 28
    Larsen JK. Washless double staining of a nuclear antigen (Ki-67 or bromodeoxyuridine) and DNA in unfixed nuclei. Methods Cell Biol 1990; 33: 227234.
  • 29
    Rabinovitch PS. Multicycle: a program for DNA content and cell cycle analysis. Product manual. San Diego: Phoenix Flow Systems; 1991.
  • 30
    Torres K, Horwitz SB. Mechanisms of taxol-induced cell death are concentration dependent. Cancer Res 1998; 58: 36203626.
  • 31
    Fuhr JE, Frye A, Kattine AA, Vanmeter S. Flow cytometric determination of breast-tumor heterogeneity. Cancer 1991; 67: 14011405.
  • 32
    Bergers E, van Diest PJ, Baal JPA. Comparison of five cell cycle analysis models applied to 1,414 flow cytometric DNA histograms of fresh frozen breast cancer. Cytometry 1997; 30: 460.
  • 33
    Wersto RP, Liblit RL, Koss LG. Flow cytometric DNA analysis of human solid tumors: a review of the interpretation of DNA histograms. Hum Pathol 1991; 22: 10851098.
  • 34
    Shankey TV, Kallioniemi O-P, Koslowski JM, Lieber ML, Mayall BH, Miller G, Smith GJ. Consensus review of the clinical utility of DNA content cytometry in prostate cancer. Cytometry 1993; 14: 487500.
  • 35
    Kimmig R, Spelsberg H, Kapsner T, Untch M, Hepp H. Flow cytometric DNA analysis of breast cancer by two colour method using cytokeratin labeling for the identification of cells. Anal Cell Pathol 1994; 7: 205215.
  • 36
    Wingren S, Stal O, Nordenskjold B. Flow cytometric analysis of S-phase fraction in breast carcinomas using gating on cells containing cytokeratin. Br J Cancer 1994; 69: 546549.
  • 37
    Zarbo RJ, Visscher DW, Crissman JD. Two-color multiparametric method for flow cytometric DNA analysis of carcinomas using staining for cytokeratin and leukocyte-common antigen. Anal Quant Cytol Histol 1989; 11: 391402.
  • 38
    Graham ML, Bunn P, Jewett PB, Gonzalez-Aller C, Horwitz KB. Simultaneous measurement of progesterone receptors and DNA indices by flow cytometry: characterization of an assay in breast cancer cell lines. Cancer Res 1989; 49: 39343942.
  • 39
    Lee T-K, Wiley AL, Esinhart JD, Riley RS, Blackburn LD. Variations associated with disaggregation methods in DNA flow cytometry. Anal Quant Cytol Histol 1993; 15: 195200.
  • 40
    Baldetrorp B, Bendahl P-O, Ferno M, Alanen K, Delle U, Falkmer U, Hansson-Aggesjo B, Hockenstrom T, Lindgren A, Mossberg L, Nordling S, Sigurdsson H, Stal O, Visakorpi T. Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates. Cytometry 1995; 22: 115127.
  • 41
    Danesi DT, Spano M, Altavista P, Pantarotto M, Filippini C, Mazzini G, Erba E, Ubezio P. Quality control study of the Italian group of cytometry on flow cytometry DNA content measurements: II. Factors affecting inter- and intralaboratory variability. Cytometry 1997; 30: 8597.
  • 42
    Wheeless LL, Coon JS, Cox C, Deitch AD, de Vere White RW, Fradet Y, Koss LG, Melamed MR, O'Connell MJ, Reeder JE, Weinstein RS, Wersto RP. Precision of DNA flow cytometry in interinstitutional analysis. Cytometry 1991; 12: 405412.
  • 43
    Baldetorp B, Stal O, Ahrens O, Cornelisse C, Corver W, Falkmer U, Ferno M. Different calculation methods for flow cytometric S-phase fraction: prognostic implications in breast cancer? The Swedish Society of Cancer Study Group. Cytometry 1998; 33: 385393.